Epocal Acquired by Alere - Analyst Blog
12 2월 2013 - 11:20PM
Zacks
Alere (ALR), a
medical products company focused on integrating rapid diagnostics
with health management, recently revealed that it has taken over
Epocal, Inc., which is a seller of know-how that facilitates
testing for electrolytes and blood gas from a point near the
patient.
Following adjustments, Alere paid
about $166 million to take over Epocal, including a payment of $15
million for accomplishment of two milestones. If certain products
are delivered using the Epocal setup, then further payments of
$75.5 million may take place.
Alere set up a definitive agreement
with Epocal in 2009 to purchase its equity in entirety, contingent
upon the completion of fiscal milestones such as gross margin on or
before October 31, 2014.
Diagnostic tests are shifting
closer to consumers and into the home testing market, as more
diagnostic tests are being developed to monitor patients rather
than only diagnose. Alere's strategy of combining disease
management with point-of-care testing (POCT), in a manner that
encourages patients to take responsibility over their overall
health care, is viewed as a prudent approach while at the same time
ensuring affordability.
In addition to growing its revenues
through a combined strategy of continued acquisitions and measured
organic growth, the company is committed to improving its operating
margin. Further, its product pipeline is strong, which has been
developed through a combination of internal R&D as well as
serial acquisitions. One of the company’s competitors is
Abaxis (ABAX).
We currently have a Zacks Rank #4
(Sell) on Alere. We are more optimistic about ResMed
Inc. (RMD) and Conceptus, Inc. (CPTS),
which carry a Zacks Rank #1 (Strong Buy) and Zacks Rank #2 (Buy),
respectively, and are expected to do well.
ABAXIS INC (ABAX): Free Stock Analysis Report
ALERE INC (ALR): Free Stock Analysis Report
CONCEPTUS INC (CPTS): Free Stock Analysis Report
RESMED INC (RMD): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024